Skip to main content
ArticleOPEN ACCESS

Dividing paths in fatty liver disease

Nature Reviews Cancer
DOI: 10.1038/s41568-018-0086-4
2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Grohmann, Wiede et al. report that obesity-associated nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) can be driven by independent pathways. In particular, HCC can be driven by STAT3 signalling, independently from STAT1-driven NASH.

Cite

CITATION STYLE

APA

Harjes, U. (2019, January 1). Dividing paths in fatty liver disease. Nature Reviews Cancer. Nature Publishing Group. https://doi.org/10.1038/s41568-018-0086-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free